S1 guidelines: Tinea capitis.
Journal
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
ISSN: 1610-0387
Titre abrégé: J Dtsch Dermatol Ges
Pays: Germany
ID NLM: 101164708
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
entrez:
7
2
2020
pubmed:
7
2
2020
medline:
15
12
2020
Statut:
ppublish
Résumé
Tinea capitis describes a dermatophyte infection of scalp and hair that predominately occurs in children. The diagnostic workup includes microscopic examination, culture and/or molecular tests. Treatment is guided by the specific organism involved and should consist of systemic agents as well as adjuvant topical treatment. The aim of the present update of the interdisciplinary German S1 guidelines is to provide dermatologists, pediatricians and general practitioners with a decision tool for selecting and implementing appropriate diagnostic and therapeutic measures in patients with tinea capitis. The guidelines were developed based on current international guidelines, in particular the 2010 European Society for Pediatric Dermatology guidelines and the 2014 British Association of Dermatologists guidelines, as well as on a review of the literature conducted by the guideline committee. This multidisciplinary committee consists of representatives from the German Society of Dermatology (DDG), the German-Speaking Mycological Society (DMykG), the German Society for Hygiene and Microbiology (DGHM), the German Society of Pediatric and Adolescent Medicine (DGKJ) and the German Society for Pediatric Infectious Diseases (DGPI). The Division of Evidence-based Medicine (dEBM) provided methodological assistance. The guidelines were approved by the participating medical societies following a comprehensive internal and external review.
Substances chimiques
Antifungal Agents
0
Types de publication
Journal Article
Practice Guideline
Langues
eng
Sous-ensembles de citation
IM
Pagination
161-179Informations de copyright
© 2020 The Authors | Journal compilation © Blackwell Verlag GmbH, Berlin.
Références
Seebacher C, Abeck D, Brasch J et al. Tinea capitis: ringworm of the scalp. Mycoses 2007; 50: 218-26.
Kakourou T, Uksal U. Guidelines for the management of tinea capitis in children. Pediatr Dermatol 2010; 27: 226-8.
Fuller LC, Barton RC, Mohd Mustapa MF et al. British Association of Dermatologists’ guidelines for the management of tinea capitis 2014. Br J Dermatol 2014; 171: 454-63.
Ginter-Hanselmayer G, Weger W, Ilkit M, Smolle J. Epidemiology of tinea capitis in Europe: current state and changing patterns. Mycoses 2007; 50 (Suppl 2): 6-13.
Nenoff P, Handrick W, Kruger C et al. [Dermatomycoses due to pets and farm animals: neglected infections?]. Hautarzt 2012; 63: 848-58.
Uhrlass S, Kruger C, Nenoff P. [Microsporum canis: Current data on the prevalence of the zoophilic dermatophyte in central Germany]. Hautarzt 2015; 66: 855-62.
Ziegler W, Lempert S, Goebeler M, Kolb-Maurer A. Tinea capitis: Erregerspektrum und Epidemiologie im zeitlichen Wandel. J Dtsch Dermatol Ges 2016; 14: 818-26.
Borman AM, Campbell CK, Fraser M, Johnson EM. Analysis of the dermatophyte species isolated in the British Isles between 1980 and 2005 and review of worldwide dermatophyte trends over the last three decades. Med Mycol 2007; 45: 131-41.
Panasiti V, Devirgiliis V, Borroni RG et al. Epidemiology of dermatophytic infections in Rome, Italy: a retrospective study from 2002 to 2004. Med Mycol 2007; 45: 57-60.
Valdigem GL, Pereira T, Macedo C et al. A twenty-year survey of dermatophytoses in Braga, Portugal. Int J Dermatol 2006; 45: 822-7.
Saunte DM, Svejgaard EL, Haedersdal M et al. Laboratory-based survey of dermatophyte infections in Denmark over a 10-year period. Acta Derm Venereol 2008; 88: 614-6.
Jankowska-Konsur A, Dylag M, Szepietowski JC. Tinea capitis in southwest Poland. Mycoses 2009; 52: 193-4.
Drakensjo IT, Chryssanthou E. Epidemiology of dermatophyte infections in Stockholm, Sweden: a retrospective study from 2005-2009. Med Mycol 2011; 49: 484-8.
delBoz J, Crespo V, Rivas-Ruiz F, de Troya M. A 30-year survey of paediatric tinea capitis in southern Spain. J Eur Acad Dermatol Venereol 2011; 25: 170-4.
Alshawa K, Lacroix C, Benderdouche M et al. Increasing incidence of Trichophyton tonsurans in Paris, France: a 15-year retrospective study. Br J Dermatol 2012; 166: 1149-50.
Nasir S, Ralph N, O’Neill C et al. Trends in tinea capitis in an Irish pediatric population and a comparison of scalp brushings versus scalp scrapings as methods of investigation. Pediatr Dermatol 2014; 31: 622-3.
Gits-Muselli M, Benderdouche M, Hamane S et al. Continuous increase of Trichophyton tonsurans as a cause of tinea capitis in the urban area of Paris, France: a 5-year-long study. Med Mycol 2017; 55: 476-84.
Chokoeva AA, Zisova L, Sotiriou E, Miteva-Katrandzhieva T. Tinea capitis: a retrospective epidemiological comparative study. Wien Med Wochenschr 2017; 167: 51-7.
Binder B, Lackner HK, Poessl BD et al. Prevalence of tinea capitis in Southeastern Austria between 1985 and 2008: up-to-date picture of the current situation. Mycoses 2011; 54: 243-7.
Foster KW, Ghannoum MA, Elewski BE. Epidemiologic surveillance of cutaneous fungal infection in the United States from 1999 to 2002. J Am Acad Dermatol 2004; 50: 748-52.
Brasch J, Ruther T, Harmsen D. [Trichophyton tonsurans var. sulfureum subvar. perforans in Tinea gladiatorum]. Hautarzt 1999; 50: 363-7.
Mayser P, Handrick W, Nenoff P. [Sports-associated dermatophytoses: An overview]. Hautarzt 2016; 67: 680-8.
Mayser P. Mykosen. In: Plewig G, Ruzicka T, Kaufmann R, Hertl M: Braun-Falco’s Dermatologie, Venerologie und Allergologie: Springer Verlag, 2018: 261-97.
Hay RJ. Tinea Capitis: Current Status. Mycopathologia 2017; 182: 87-93.
Larralde M, Gomar B, Boggio P et al. Neonatal kerion Celsi: report of three cases. Pediatr Dermatol 2010; 27: 361-3.
Atanasovski M, El Tal AK, Hamzavi F, Mehregan DA. Neonatal dermatophytosis: report of a case and review of the literature. Pediatr Dermatol 2011; 28: 185-8.
Zampella JG, Kwatra SG, Blanck J, Cohen B. Tinea in tots: cases and literature review of oral antifungal treatment of tinea capitis in children under 2 years of age. J Pediatr 2017; 183: 12-18.e3.
Fremerey C, Nenoff P. Tinea capitis in a newborn. N Engl J Med 2018; 378: 2022.
Rothman S, Smiljanic A et al. The spontaneous cure of tinea capitis in puberty. J Invest Dermatol 1947; 8: 81-98.
Zhang R, Ran Y, Dai Y et al. A case of kerion celsi caused by Microsporum gypseum in a boy following dermatoplasty for a scalp wound from a road accident. Med Mycol 2011; 49: 90-3.
Proudfoot LE, Higgins EM, Morris-Jones R. A retrospective study of the management of pediatric kerion in Trichophyton tonsurans infection. Pediatr Dermatol 2011; 28: 655-7.
Ilkit M. Favus of the scalp: an overview and update. Mycopathologia 2010; 170: 143-54.
Nenoff P, Kruger C, Schulze I et al. [Tinea capitis and onychomycosis due to Trichophyton soudanense: Successful treatment with fluconazole-literature review]. Hautarzt 2018; 69: 737-50.
Kawachi Y, Ikegami M, Takase T, Otsuka F. Chronically recurrent and disseminated tinea faciei/corporis-autoinoculation from asymptomatic tinea capitis carriage. Pediatr Dermatol 2010; 27: 527-8.
Sterling JB, Sina B, Gaspari A, Deng A. Acne keloidalis: a novel presentation for tinea capitis. J Am Acad Dermatol 2007; 56: 699-701.
Ziemer A, Kohl K, Schroder G. Trichophyton rubrum-induced inflammatory tinea capitis in a 63-year-old man. Mycoses 2005; 48: 76-9.
Cheng N, Rucker Wright D, Cohen BA. Dermatophytid in tinea capitis: rarely reported common phenomenon with clinical implications. Pediatrics 2011; 128: e453-7.
Topaloglu Demir F, Karadag AS. Are dermatophytid reactions in patients with kerion celsi much more common than previously thought? A prospective study. Pediatr Dermatol 2015; 32: 635-40.
Ilkit M, Durdu M, Karakas M. Cutaneous id reactions: a comprehensive review of clinical manifestations, epidemiology, etiology, and management. Crit Rev Microbiol 2012; 38: 191-202.
Mayser P. [Dermatophyte: Current situation]. Hautarzt 2017; 68: 316-23.
Zaraa I, Trojjet S, El Guellali N et al. Childhood erythema nodosum associated with kerion celsi: a case report and review of literature. Pediatr Dermatol 2012; 29: 479-82.
Castriota M, Ricci F, Paradisi A et al. Erythema nodosum induced by kerion celsi of the scalp in a child: a case report and mini-review of literature. Mycoses 2013; 56: 200-3.
Liu ZH, Shen H, Xu AE. Severe kerion with dermatophytid reaction presenting with diffuse erythema and pustules. Mycoses 2011; 54: e650-2.
Ronjat L, Ferneiny M, Hadj-Rabia S et al. [Generalized exanthematous pustular dermatophytid, a rare clinical presentation of dermatophytid reaction]. Ann Dermatol Venereol 2015; 142: 270-5.
White JM, Higgins EM, Fuller LC. Screening for asymptomatic carriage of Trichophyton tonsurans in household contacts of patients with tinea capitis: results of 209 patients from South London. J Eur Acad Dermatol Venereol 2007; 21: 1061-4.
Friedlander SF, Pickering B, Cunningham BB et al. Use of the cotton swab method in diagnosing Tinea capitis. Pediatrics 1999; 104: 276-9.
Bonifaz A, Isa-Isa R, Araiza J et al. Cytobrush-culture method to diagnose tinea capitis. Mycopathologia 2007; 163: 309-13.
Kupsch C, Berlin M, Graser Y. [Dermophytes and guinea pigs: An underestimated danger?]. Hautarzt 2017; 68: 827-30.
Robert R, Pihet M. Conventional methods for the diagnosis of dermatophytosis. Mycopathologia 2008; 166: 295-306.
Verrier J, Krahenbuhl L, Bontems O et al. Dermatophyte identification in skin and hair samples using a simple and reliable nested polymerase chain reaction assay. Br J Dermatol 2013; 168: 295-301.
Sugita T, Shiraki Y, Hiruma M. Real-time PCR TaqMan assay for detecting Trichophyton tonsurans, a causative agent of tinea capitis, from hairbrushes. Med Mycol 2006; 44: 579-81.
Verrier J, Monod M. Diagnosis of dermatophytosis using molecular biology. Mycopathologia 2017; 182: 193-202.
Kupsch C, Czaika VA, Deutsch C, Graser Y. Trichophyton mentagrophytes - a new genotype of zoophilic dermatophyte causes sexually transmitted infections. J Dtsch Dermatol Ges 2019; 17: 493-501.
Wiegand C, Mugisha P, Mulyowa GK et al. Identification of the causative dermatophyte of tinea capitis in children attending Mbarara Regional Referral Hospital in Uganda by PCR-ELISA and comparison with conventional mycological diagnostic methods. Med Mycol 2017; 55: 660-8.
Ghannoum MA, Wraith LA, Cai B et al. Susceptibility of dermatophyte isolates obtained from a large worldwide terbinafine tinea capitis clinical trial. Br J Dermatol 2008; 159: 711-3.
Gupta AK, Williams JV, Zaman M, Singh J. In vitro pharmacodynamic characteristics of griseofulvin against dermatophyte isolates of Trichophyton tonsurans from tinea capitis patients. Med Mycol 2009; 47: 796-801.
Miteva M, Tosti A. Hair and scalp dermatoscopy. J Am Acad Dermatol 2012; 67: 1040-8.
Mapelli ET, Gualandri L, Cerri A, Menni S. Comma hairs in tinea capitis: a useful dermatoscopic sign for diagnosis of tinea capitis. Pediatr Dermatol 2012; 29: 223-4.
Hughes R, Chiaverini C, Bahadoran P, Lacour JP. Corkscrew hair: a new dermoscopic sign for diagnosis of tinea capitis in black children. Arch Dermatol 2011; 147: 355-6.
Brasileiro A, Campos S, Cabete J et al. Trichoscopy as an additional tool for the differential diagnosis of tinea capitis: a prospective clinical study. Br J Dermatol 2016; 175: 208-9.
Tang J, Ran X, Ran Y. Ultraviolet dermoscopy for the diagnosis of tinea capitis. J Am Acad Dermatol 2017; 76: S28-S30.
Vazquez-Lopez F, Palacios-Garcia L, Argenziano G. Dermoscopic corkscrew hairs dissolve after successful therapy of Trichophyton violaceum tinea capitis: a case report. Australas J Dermatol 2012; 53: 118-9.
Richarz NA, Barboza L, Monsonis M et al. Trichoscopy helps to predict the time point of clinical cure of tinea capitis. Australas J Dermatol 2018; 59: e298-e299.
Thoma-Greber E, Zenker S, Rocken M et al. Surgical treatment of tinea capitis in childhood. Mycoses 2003; 46: 351-4.
von Laer Tschudin L, Laffitte E, Baudraz-Rosselet F et al. Tinea capitis: no incision nor excision. J Pediatr Surg 2007; 42: E33-6.
Allen HB, Honig PJ, Leyden JJ, McGinley KJ. Selenium sulfide: adjunctive therapy for tinea capitis. Pediatrics 1982; 69: 81-3.
Chen C, Koch LH, Dice JE et al. A randomized, double-blind study comparing the efficacy of selenium sulfide shampoo 1 % and ciclopirox shampoo 1 % as adjunctive treatments for tinea capitis in children. Pediatr Dermatol 2010; 27: 459-62.
Gupta AK, Mays RR, Versteeg SG et al. Tinea capitis in children: a systematic review of management. J Eur Acad Dermatol Venereol 2018; 32: 2264-74.
Chen X, Jiang X, Yang M et al. Systemic antifungal therapy for tinea capitis in children. Cochrane Database Syst Rev. 2016: Cd004685.
Chen X, Jiang X, Yang M et al. Systemic antifungal therapy for tinea capitis in children: An abridged Cochrane Review. J Am Acad Dermatol 2017; 76: 368-74.
Binder B, Richtig E, Weger W, Ginter-Hanselmayer G. Tinea capitis in early infancy treated with itraconazole: a pilot study. J Eur Acad Dermatol Venereol 2009; 23: 1161-3.
Gupta AK, Cooper EA, Bowen JE. Meta-analysis: griseofulvin efficacy in the treatment of tinea capitis. J Drugs Dermatol 2008; 7: 369-72.
Gupta AK, Drummond-Main C. Meta-analysis of randomized, controlled trials comparing particular doses of griseofulvin and terbinafine for the treatment of tinea capitis. Pediatr Dermatol 2013; 30: 1-6.
Elewski BE, Caceres HW, De Leon L et al. Terbinafine hydrochloride oral granules versus oral griseofulvin suspension in children with tinea capitis: results of two randomized, investigator-blinded, multicenter, international, controlled trials. J Am Acad Dermatol 2008; 59: 41-54.
Foster KW, Friedlander SF, Panzer H et al. A randomized controlled trial assessing the efficacy of fluconazole in the treatment of pediatric tinea capitis. J Am Acad Dermatol 2005; 53: 798-809.
Devliotou-Panagiotidou D, Koussidou-Eremondi TH. Efficacy and tolerability of 8 weeks’ treatment with terbinafine in children with tinea capitis caused by Microsporum canis: a comparison of three doses. J Eur Acad Dermatol Venereol 2004; 18: 155-9.
Ginter-Hanselmayer G, Smolle J, Gupta A. Itraconazole in the treatment of tinea capitis caused by Microsporum canis: experience in a large cohort. Pediatr Dermatol 2004; 21: 499-502.
Lipozencic J, Skerlev M, Orofino-Costa R et al. A randomized, double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species. Br J Dermatol 2002; 146: 816-23.
Friedlander SF, Aly R, Krafchik B et al. Terbinafine in the treatment of Trichophyton tinea capitis: a randomized, double-blind, parallel-group, duration-finding study. Pediatrics 2002; 109: 602-7.
Fuller LC, Smith CH, Cerio R et al. A randomized comparison of 4 weeks of terbinafine vs. 8 weeks of griseofulvin for the treatment of tinea capitis. Br J Dermatol 2001; 144: 321-7.
Gupta AK, Ginter G. Itraconazole is effective in the treatment of tinea capitis caused by Microsporum canis. Pediatr Dermatol 2001; 18: 519-22.
Gupta AK, Adam P, Dlova N et al. Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole. Pediatr Dermatol 2001; 18: 433-8.
Pharmainternational. Auskunft. Available from: https://www.pharmainternational.de/index.php/de/ [Last accessed October 30, 2019].
Haedersdal M, Svejgaard EL. Once-weekly fluconazole in children with tinea capitis due to Microsporum canis. Acta Derm Venereol 2005; 85: 177-8.
Gupta AK, Dlova N, Taborda P et al. Once weekly fluconazole is effective in children in the treatment of tinea capitis: a prospective, multicentre study. Br J Dermatol 2000; 142: 965-8.
Ginter-Hanselmayer G, Seebacher C. Treatment of tinea capitis - a critical appraisal. J Dtsch Dermatol Ges 2011; 9: 109-14.
Faergemann J, Zehender H, Jones T, Maibach I. Terbinafine levels in serum, stratum corneum, dermis-epidermis (without stratum corneum), hair, sebum and eccrine sweat. Acta Derm Venereol 1991; 71: 322-6.
Cauwenbergh G, Degreef H, Heykants J et al. Pharmacokinetic profile of orally administered itraconazole in human skin. J Am Acad Dermatol 1988; 18: 263-8.
Wildfeuer A, Faergemann J, Laufen H et al. Bioavailability of fluconazole in the skin after oral medication. Mycoses 1994; 37: 127-30.
Gupta AK, Groen K, Woestenborghs R, De Doncker P. Itraconazole pulse therapy is effective in the treatment of Majocchi’s granuloma: a clinical and pharmacokinetic evaluation and implications for possible effectiveness in tinea capitis. Clin Exp Dermatol 1998; 23: 103-8.
Geissel B, Loiko V, Klugherz I et al. Azole-induced cell wall carbohydrate patches kill Aspergillus fumigatus. Nat Commun 2018; 9: 3098.
Gubbins PO, Heldenbrand S. Clinically relevant drug interactions of current antifungal agents. Mycoses 2010; 53: 95-113.
Durrbeck A, Nenoff P. [Terbinafine: Relevant drug interactions and their management]. Hautarzt 2016; 67: 718-23.
Groll AH, Lehmbecher T. Antimykotika. In: DGPI: DGPI Handbuch-Infektionen bei Kindern und Jugendlichen. Stuttgart: Georg Thieme 2018: 103-9.
Shemer A, Plotnik IB, Davidovici B et al. Treatment of tinea capitis - griseofulvin versus fluconazole - a comparative study. J Dtsch Dermatol Ges 2013; 11: 737-41, 37-42.
Ghannoum M, Isham N, Sheehan D. Voriconazole susceptibilities of dermatophyte isolates obtained from a worldwide tinea capitis clinical trial. J Clin Microbiol 2006; 44: 2579-80.
Mohrenschlager M, Seidl HP, Ring J, Abeck D. Pediatric tinea capitis: recognition and management. Am J Clin Dermatol 2005; 6: 203-13.
Stolmeier DA, Stratman HB, McIntee TJ, Stratman EJ. Utility of laboratory test result monitoring in patients taking oral terbinafine or griseofulvin for dermatophyte infections. JAMA Dermatol 2018; 154: 1409-16.
Patel D, Castelo-Soccio LA, Rubin AI, Streicher JL. Laboratory monitoring during systemic terbinafine therapy for pediatric onychomycosis. JAMA Dermatol 2017; 153: 1326-7.
Kramer ON, Albrecht J. Clinical presentation of terbinafine-induced severe liver injury and the value of laboratory monitoring: a critically appraised topic. Br J Dermatol 2017; 177: 1279-84.
Aste N, Pau M, Biggio P. Tinea capitis in children in the district of Cagliari, Italy. Mycoses 1997; 40: 231-3.
Bundesministerium der Justiz und für Verbraucherschutz. Infektionsschutzgesetz, 2001, in der aktualisierten Fassung vom 17.7.2017. Available from: http://www.gesetze-im-internet.de/ifsg/index.html [last accessed October 30, 2019].
Braubach A, Kieth S, Heyer I. Microsporum audouinii: Management eines Ausbruchs in Bonner Gemeinschaftseinrichtungen im Jahr 2015. Epidemiologisches Bulletin 2019: 39-45.
Donghi D, Hauser V, Bosshard PP. Microsporum audouinii tinea capitis in a Swiss school: assessment and management of patients and asymptomatic carriers. Med Mycol 2011; 49: 324-8.
Lehmann T, Budihardja D, Gries A, Mayser P. An epidemic outbreak of tinea capitis caused by Trichophyton tonsurans in a kindergarten in Rhineland-Palatinate. Mycoses 2011; 54: 382-3.
Shroba J, Olson-Burgess C, Preuett B, Abdel-Rahman SM. A large outbreak of Trichophyton tonsurans among health care workers in a pediatric hospital. Am J Infect Control 2009; 37: 43-8.
Zink A, Papanagiotou V, Todorova A et al. Outbreak of Microsporum audouinii in Munich - the return of infectious fungi in Germany. Mycoses 2014; 57: 765-70.
Grills CE, Bryan PL, O’Moore E, Venning VA. Microsporum canis: report of a primary school outbreak. Australas J Dermatol 2007; 48: 88-90.
Mackenzie DW. “Hairbrush Diagnosis” in detection and eradication of non-fluorescent scalp ringworm. Br Med J 1963; 2: 363-5.
Hammer TR, Mucha H, Hoefer D. Infection risk by dermatophytes during storage and after domestic laundry and their temperature-dependent inactivation. Mycopathologia 2011; 171: 43-9.
Mayser P. [Treatment of dermatoses: Significance and use of glucocorticoids in fixed combination with antifungals]. Hautarzt 2016; 67: 732-8.
Schaller M, Friedrich M, Papini M et al. Topical antifungal-corticosteroid combination therapy for the treatment of superficial mycoses: conclusions of an expert panel meeting. Mycoses 2016; 59: 365-73.
Hussain I, Muzaffar F, Rashid T et al. A randomized, comparative trial of treatment of kerion celsi with griseofulvin plus oral prednisolone vs. griseofulvin alone. Med Mycol 1999; 37: 97-9.
Ginsburg CM, Gan VN, Petruska M. Randomized controlled trial of intralesional corticosteroid and griseofulvin vs. griseofulvin alone for treatment of kerion. Pediatr Infect Dis J 1987; 6: 1084-7.